E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/23/2015 in the Prospect News High Yield Daily.

Labco/Synlab sets pricing on upsized €1.06 billion three-part notes ahead of final terms Thursday

By Paul A. Harris

Portland, Ore., July 23 – Dealers set tranches sizes and pricing on an upsized €1.06 billion offering of high-yield notes backing the acquisition of Germany-based Synlab, according to a market source.

Final terms are expected later Thursday.

The Labco/Synlab deal, the overall size of which has been increased from €1.05 billion, is coming in three tranches, two secured and one unsecured.

Ephios Bondco plc is selling an upsized €685 million of Labco secured notes due July 1, 2022 (B2/B+/B+) in two add-on tranches.

Included is a €400 million add-on to the 6¼% notes set to price at 99. The original €500 million issue priced at par on June 12, 2015.

A €285 million add-on to the Euribor plus 500 basis points notes is also set to price at 99. The original €300 million issue priced 99.5 on June 12, 2015.

The combined size of the secured portion of the deal is increased from €675 million.

Lead left bookrunner JPMorgan will bill and deliver for the secured notes.

Ephios Holdco II plc is selling €375 million of new eight-year senior unsecured notes (Caa1/B-/CCC+), callable after three years at par plus 75% of the coupon and set to yield 8¼%.

Lead left bookrunner Goldman Sachs will bill and deliver for the unsecured notes.

JPMorgan and Goldman Sachs are the global coordinators for the Rule 144A and Regulation S for life deal.

Barclays, Deutsche Bank, BNP Paribas, HSBC and Morgan Stanley are the joint bookrunners.

Proceeds will be used to finance the acquisition of Synlab by Cinven. The additional €10 million of proceeds resulting from the upsize will be used to fund the original issue discounts.

Synlab is an Augsburg, Germany-based laboratory services provider.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.